RU2011128758A - PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION - Google Patents
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION Download PDFInfo
- Publication number
- RU2011128758A RU2011128758A RU2011128758/15A RU2011128758A RU2011128758A RU 2011128758 A RU2011128758 A RU 2011128758A RU 2011128758/15 A RU2011128758/15 A RU 2011128758/15A RU 2011128758 A RU2011128758 A RU 2011128758A RU 2011128758 A RU2011128758 A RU 2011128758A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- levofloxacin
- hydrochloride
- protionamide
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Фармацевтическая композиция с противотуберкулезным действием, включающая терапевтически эффективное количество действующего начала, в качестве которого содержит комбинацию левофлоксацина, протионамида, пиразинамида, этамбутола гидрохлорида и пиридоксина гидрохлорида, и, по меньшей мере, одно фармацевтически приемлемое вспомогательное вещество.2. Фармацевтическая композиция по п.1, характеризующаяся тем, что включает ингредиенты действующего начала при следующем соотношении, мас.ч.:3. Фармацевтическая композиция по п.1, характеризующаяся тем, что она выполнена в виде твердой лекарственной формы.4. Фармацевтическая композиция по п.3, характеризующаяся тем, что она выполнена в форме таблетки.5. Фармацевтическая композиция по п.4, характеризующаяся тем, что она содержит в качестве вспомогательных веществ прежелатинизированный крахмал, повидон, макрогол, кремния диоксид коллоидный, натрия кроскармеллозу, тальк, натрия стеарилфумарат, кислоту стеариновую и соль стеариновой кислоты.6. Фармацевтическая композиция по п.4, характеризующаяся тем, что она имеет оболочку.7. Фармацевтическая композиция по любому из пп.3-6, характеризующаяся тем, что содержит ингредиенты действующего начала в единичной дозе в следующем количестве, мг:8. Фармацевтическая композиция по п.7, характеризующаяся тем, что включает левофлоксацин в виде гемигидрата.9. Применение комбинации левофлоксацина, протионамида, пиразинамида, этамбутола гидрохлорида и пиридоксина гидрохлорида для изготовления композиции с противотуберкулезным действием.10. Применение по п.9, по которому левофлоксацин используется в виде гемигидрата.1. A pharmaceutical composition with an anti-tuberculosis effect, comprising a therapeutically effective amount of an active principle, which contains a combination of levofloxacin, protionamide, pyrazinamide, ethambutol hydrochloride and pyridoxine hydrochloride, and at least one pharmaceutically acceptable excipient. 2. The pharmaceutical composition according to claim 1, characterized in that it includes the ingredients of the active principle in the following ratio, parts by weight: 3. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of a solid dosage form. The pharmaceutical composition according to claim 3, characterized in that it is made in the form of tablets. The pharmaceutical composition according to claim 4, characterized in that it contains pregelatinized starch, povidone, macrogol, colloidal silicon dioxide, croscarmellose sodium, talc, sodium stearyl fumarate, stearic acid and stearic acid salt as excipients. The pharmaceutical composition according to claim 4, characterized in that it has a shell. The pharmaceutical composition according to any one of claims 3 to 6, characterized in that it contains the ingredients of the active principle in a single dose in the following amount, mg: 8. The pharmaceutical composition according to claim 7, characterized in that it comprises levofloxacin in the form of a hemihydrate. The use of a combination of levofloxacin, protionamide, pyrazinamide, ethambutol hydrochloride and pyridoxine hydrochloride for the manufacture of a composition with anti-tuberculosis action. 10. The use according to claim 9, in which levofloxacin is used in the form of hemihydrate.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011128758/15A RU2478389C2 (en) | 2011-07-12 | 2011-07-12 | Pharmaceutical anti-tuberculosis combined composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011128758/15A RU2478389C2 (en) | 2011-07-12 | 2011-07-12 | Pharmaceutical anti-tuberculosis combined composition |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011128758A true RU2011128758A (en) | 2013-01-20 |
RU2478389C2 RU2478389C2 (en) | 2013-04-10 |
Family
ID=48805060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011128758/15A RU2478389C2 (en) | 2011-07-12 | 2011-07-12 | Pharmaceutical anti-tuberculosis combined composition |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2478389C2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2247560C1 (en) * | 2003-12-29 | 2005-03-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Composite formulation with antituberculous activity |
RU2354378C1 (en) * | 2007-07-09 | 2009-05-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Combined anti-tuberculosis preparation |
RU2009134910A (en) * | 2009-09-14 | 2011-03-20 | Открытое Акционерное Общество "Фармасинтез" (Ru) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION |
-
2011
- 2011-07-12 RU RU2011128758/15A patent/RU2478389C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2478389C2 (en) | 2013-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2015107877A (en) | METHODS FOR TREATING ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITIONS | |
RU2017107760A (en) | Compound | |
JP2018530566A5 (en) | ||
JP2016530238A5 (en) | ||
RU2014143529A (en) | Crystalline forms of (S) -4-amino-N- (1- (4-chlorophenyl) -3-hydroxypropyl) -1- (7H-pyrrolo [2, 3-d] pyrimidin-4-yl) piperidin-4-carboxamide | |
RU2011128758A (en) | PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | |
RU2013149635A (en) | SOLIFENACIN COMPOUNDS AND SALIVARY STIMULANTS FOR THE TREATMENT OF URINE BUBBLE HYPERACTIVITY | |
RU2019140298A (en) | The combination, its use and methods of treatment using the specified combination | |
MX2023001014A (en) | Pharmaceutical compositions comprising venglustat. | |
CN114945371A (en) | Treatment of mast cell diseases and eosinophilic diseases | |
RU2013157796A (en) | PHARMACEUTICAL COMPOSITION BASED ON MOXIFLOXACIN | |
RU2011104563A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ARTERIAL HYPERTENSION AND CONSTANT HEART FAILURE AND METHOD FOR ITS PRODUCTION | |
RU2009134910A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
RU2010131342A (en) | PHARMACEUTICAL COMPOSITION (OPTIONS) FOR PREVENTION AND TREATMENT OF DISEASES OF THE NERVOUS SYSTEM AND METHOD OF ITS PRODUCTION | |
RU2012121055A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION | |
RU2007125596A (en) | COMBINED TUBERCULOSIS DRUG | |
RU2015125236A (en) | COMBINED PHARMACEUTICAL MEDICINE CONTAINING A SELECTIVE Slow Calcium CHANNEL BLOCKER AND HMG-CoA REDUCASE INHIBITOR | |
CU24515B1 (en) | PHARMACEUTICAL DOSAGE FORMS INCLUDING 1- [6- (MORFOLIN-4-IL) PYRIMIDIN-4-IL] -4- (1H-1,2,3-TRIAZOL-1-IL) -1H-PIRAZOL-5-OLATE OF SODIUM | |
RU2736479C1 (en) | Excipient-free pharmaceutical composition containing fenosanic acid | |
RU2010142333A (en) | MEANS OF ANTIVIRAL AND IMMUNITY OF MULTI-ACTIVITY, METHOD OF PRODUCING ANTIVIRAL AND IMMUNITY OF MULTI-ACTIVITY, METHOD OF PREVENTION AND TREATMENT OF INFECTIOUS DISEASES | |
RU2010134123A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES | |
RU2009132616A (en) | PHARMACEUTICAL COMPOSITION OF LONG-TERM ACTION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | |
RU2009134473A (en) | COMBINED TUBERCULOSIS DRUG | |
RU2013121820A (en) | COMBINED MEDICINE FOR THE ELIMINATION OF SYMPTOMS AND TREATMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS AND INFLUENZA | |
RU2007140431A (en) | PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20180713 |